BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on noradrenaline

Active substance: noradrenaline

The company Aguettant issues information on the marketing of a solution for infusion containing noradrenaline in two new ready-for-use strengths.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 3MB, File is accessible